InvestorsHub Logo
Followers 6
Posts 925
Boards Moderated 0
Alias Born 09/28/2012

Re: rod5247 post# 4227

Wednesday, 11/25/2015 12:20:49 PM

Wednesday, November 25, 2015 12:20:49 PM

Post# of 9156
You're welcome. So, my impression is that the bad news is that Roche has practically no competition from biosimilars for Herceptin and Mabthera right now, but the good news is that there will probably be a lot of competition in a year or so.

In the meantime, stock is acting well and it feels like we'll get some good news soon.

I'm also comforted that BB Biotech and FMR added to their positions and Baker Bros. did not sell in the last quarter.

The next six months could be very exciting for HALO.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent HALO News